BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/13/2026 10:24:33 AM | Browse: 16 | Download: 2
Publication Name World Journal of Stem Cells
Manuscript ID 124057
DOI 10.4252/wjsc.124057
Country China
Category Cell & Tissue Engineering
Manuscript Type Basic Study
Article Title Restoration of inflammatory responsiveness by metformin in endothelial cells derived from Marfan syndrome patient-specific induced pluripotent stem cells
Manuscript Source Unsolicited Manuscript
All Author List Yu-Hao Chen, Min-Jie Hu, Jin-Biao Lai, Lu Ding, Mi-Qi Zhou, Run-Ze Dong, Xiao-Li Ren, Cong-Kuo Du, Xue-Jiao Chen, Xiu-Fang Chen, Xiao-Fang Fan, Yong-Sheng Gong, Yong-Yu Wang and Pei-Feng Jin
Funding Agency and Grant Number
Funding Agency Grant Number
Wenzhou Municipal Science and Technology Bureau of China ZY2022009
Corresponding Author Pei-Feng Jin, Department of Cardiac Surgery, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Nanbaixiang Street, Ouhai District, Wenzhou 325000, Zhejiang Province, China. ericifeng@163.com
Key Words Marfan syndrome; Endothelial dysfunction; Patient-specific induced pluripotent stem cells; Inflammatory responses; Thoracic aortic aneurysm and dissection; Metformin; Resveratrol
Core Tip This study establishes a patient-specific endothelial cell model of Marfan syndrome (MFS) and identifies an inflammatory phenotype characterized by heightened basal inflammation but impaired responsiveness to inflammatory stimuli. These findings provide new insights into endothelial dysfunction in MFS. Importantly, metformin and resveratrol exert distinct anti-inflammatory effects, with metformin partially restoring inflammatory responsiveness and resveratrol suppressing basal inflammation, highlighting their potential as complementary therapeutic strategies for reducing vascular risk in MFS.
Citation Chen YH, Hu MJ, Lai JB, Ding L, Zhou MQ, Dong RZ, Ren XL, Du CK, Chen XJ, Chen XF, Fan XF, Gong YS, Wang YY, Jin PF. Restoration of inflammatory responsiveness by metformin in endothelial cells derived from Marfan syndrome patient-specific induced pluripotent stem cells. World J Stem Cells 2026; In press
PDF 124057-in-press.pdf
Received
2026-07-14 10:59
Peer-Review Started
2026-07-14 10:59
First Decision by Editorial Office Director
Return for Revision
2026-08-05 03:30
Revised
2026-09-04 10:07
Publication Fee Transferred
2026-10-09 02:35
Second Decision by Editor
2026-11-13 03:27
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-13 10:24
Articles in Press
2026-11-13 10:24
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com